FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP) Business, Medical, Health, Marketing, Media, Stocks, Financial
synseer Nominated for Best Startup in 2026 Prix Galien USA Awards Following Record Breaking Applicant Pool Medical, Health, Artificial Intelligence